Literature DB >> 2501814

Effects of chronic alprazolam treatment on plasma concentrations of glucocorticoids, thyroid hormones, and testosterone in cardiomyopathic hamsters.

J E Ottenweller1, W N Tapp, B H Natelson.   

Abstract

In the first of two experiments, young male cardiomyopathic hamsters were injected intraperitoneally twice a day for 29 days with 8 mg alprazolam/kg body weight or saline. Three hours after the same injections on day 30, they were sacrificed and plasma hormone levels were measured. Alprazolam increased cortisol, total glucocorticoid and triiodothyronine levels. It did not affect corticosterone, thyroxine or testosterone levels. The same protocol was used in a second experiment, except the controls received vehicle and a third group was treated with 48 mg diazepam/kg body weight. Alprazolam again increased cortisol and total glucocorticoid levels, but not those of corticosterone. On the other hand, diazepam increased both cortisol and corticosterone levels. These experiments suggest that chronic benzodiazepine treatment can affect adrenocortical function and perhaps some aspects of thyroid function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2501814     DOI: 10.1007/bf00451689

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  The effect of minor tranquilizers on stress-induced increases in rat plasma corticosteroids.

Authors:  R A Lahti; C Barsuhn
Journal:  Psychopharmacologia       Date:  1974-02-27

2.  Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.

Authors:  D B Carr; D V Sheehan; O S Surman; J H Coleman; D J Greenblatt; G R Heninger; K J Jones; P H Levine; W D Watkins
Journal:  Am J Psychiatry       Date:  1986-04       Impact factor: 18.112

3.  Adrenal, thyroid, and testicular hormone rhythms in male golden hamsters on long and short days.

Authors:  J E Ottenweller; W N Tapp; D L Pitman; B H Natelson
Journal:  Am J Physiol       Date:  1987-08

4.  Suppression of prolactin secretion by benzodiazepines in vivo.

Authors:  L Grandison
Journal:  Neuroendocrinology       Date:  1982       Impact factor: 4.914

5.  Aging, stress, and chronic disease interact to suppress plasma testosterone in Syrian hamsters.

Authors:  J E Ottenweller; W N Tapp; D Creighton; B H Natelson
Journal:  J Gerontol       Date:  1988-11

Review 6.  Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.

Authors:  G W Dawson; S G Jue; R N Brogden
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

7.  The disposition and metabolism of a hypnotic benzodiazepine, quazepam, in the hamster and mouse.

Authors:  J Hilbert; B Pramanik; S Symchowicz; N Zampaglione
Journal:  Drug Metab Dispos       Date:  1984 Jul-Aug       Impact factor: 3.922

8.  Effects of psychoactive drugs on plasma catecholamines during stress in rats.

Authors:  W H Vogel; J Miller; K H DeTurck; B K Routzahn
Journal:  Neuropharmacology       Date:  1984-09       Impact factor: 5.250

9.  Plasma cortisol and corticosterone concentrations in the golden hamster, (Mesocricetus auratus).

Authors:  J E Ottenweller; W N Tapp; J M Burke; B H Natelson
Journal:  Life Sci       Date:  1985-10-21       Impact factor: 5.037

10.  Alprazolam reduces stress hyperglycemia in ob/ob mice.

Authors:  R S Surwit; J A McCubbin; C M Kuhn; D McGee; D Gerstenfeld; M N Feinglos
Journal:  Psychosom Med       Date:  1986 Mar-Apr       Impact factor: 4.312

View more
  2 in total

1.  A potential relationship between diffuse musculoskeletal pain and hypogonadism.

Authors:  Jaclyn K Anderson; Rebecca Tuetken; Valerie Hoffman
Journal:  BMJ Case Rep       Date:  2010-01-13

2.  Effects of clozapine and haloperidol treatment on plasma concentrations of androgen hormones and androgendependent organ changes in rats.

Authors:  Afshin Samadi; Selen Yilmaz Isikhan; Mohammad Hasan Khadem Ansari; Mahshid Samadi; Suna Sabuncuoglu
Journal:  Indian J Pharmacol       Date:  2019 Jul-Aug       Impact factor: 1.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.